References
S. Lloyd and M. Franklin,Toxicol. Lett.,55(1), 65–75 (1991).
R. Speck, C. Schranz, and B. Lauterburg,J. Hepatol.,18(1), 62–67 (1993).
A. S. Saratikov and A. I. Vengerovskii,Eksp. Klin. Farmakol., No. 1, 8–11 (1995).
K. Narinder, S. Neerja, and G. Anilk,Ind. J. Biochem. Biophys.,26(6), 371–376 (1989).
G. Petrovic, V. Ristic, S. Vrbaski, et al.,Physiol. Res.,42(1), 45–47 (1993).
N. P. Skakun, V. V. Shman'ko, and L. M. Okhrimovich,Clinical Pharmacology of Hepatoprotectors [in Russian], Zbruch, Ternopol (1995).
A. S. Saratikov, A. I. Vengerovskii, V. S. Chuchalin, et al.,Khim.-Farm. Zh.,24(6), 38–40 (1990).
A. I. Vengerovskii, N. O. Baturina, V. S. Chuchalin, and A. S. Saratikov,Khim.-Farm. Zh.,29(2), 3–4 (1995).
Author information
Authors and Affiliations
Additional information
Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 32, No. 9, pp. 12–14, September, 1998.
Rights and permissions
About this article
Cite this article
Vengerovskii, A.I., Kovalenko, M.Y., Arbuzov, A.G. et al. Legalon and lokhein modify the prednisolone effects on experimental toxic hepatitis. Pharm Chem J 32, 466–468 (1998). https://doi.org/10.1007/BF02539218
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02539218